Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus

Signe Sørensen Torekov, J J Holst, M R Ehlers

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences